Can IL6 rs1800795 and CRP rs1205 shape hs-CRP levels?

Baseline levels of systemic inflammatory markers are regulated by a combination of environmental factors and a genetically determined inflammatory setpoint. Key genetic variants influence how the body maintains these baseline inflammatory states over time.

Genetic modifiers of inflammation

• IL6 rs1800795: This promoter variant (−174G>C) directly modulates interleukin-6 (IL-6) transcription. The G allele is linked to higher baseline IL-6 in healthy individuals, while the C allele is associated with elevated levels and increased disease severity in chronic inflammatory conditions.
• CRP rs1205: This variant acts as a robust modifier of circulating CRP. The CC genotype is consistently associated with elevated baseline high-sensitivity CRP (hs-CRP) and low-grade inflammation, whereas T-allele carriers exhibit significantly lower concentrations.

Mechanistic pathways and heritability

• The IL-6/CRP axis: Interleukin-6 released during systemic cytokine responses directly stimulates hepatic production of CRP, mechanistically linking the downstream effects of these two genetic variants.
• Quantile-specific heritability: Twin and family studies indicate that overall baseline hs-CRP heritability is 30% to 50%. This genetic "setpoint" is highly pronounced at the upper tail of the CRP distribution, with heritability estimated at 0.33 at the 90th percentile (above-optimal levels) compared to just 0.02 at the 10th percentile.

Bottom line

• Above-optimal hs-CRP levels are highly consistent with a genetically shaped inflammatory setpoint, where functional variants like IL6 rs1800795 and CRP rs1205 program a stable, heritable baseline predisposition to chronic low-grade inflammation.